---
title: "SC Pharmaceuticals: Expected net profit loss of 55 million to 80 million yuan in 2024"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225354951.md"
description: "SC Pharmaceuticals expects a net profit loss of 55 million to 80 million yuan in 2024, a year-on-year decrease of 8.39%-57.66%. The net profit loss after deducting non-recurring gains and losses is expected to be 58.37 million to 83.37 million yuan, a year-on-year decrease of 141.79%-245.36%. The expected operating revenue is 150 million to 190 million yuan, with the operating revenue after deductions being 140 million to 180 million yuan. The company's stock may face delisting risk warnings after the disclosure of the 2024 annual report"
datetime: "2025-01-17T12:56:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225354951.md)
  - [en](https://longbridge.com/en/news/225354951.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225354951.md)
generator: "portal-rs"
---

# SC Pharmaceuticals: Expected net profit loss of 55 million to 80 million yuan in 2024

SC Pharmaceuticals announced that it expects a net loss attributable to shareholders of the listed company for the fiscal year 2024 to be between 55 million and 80 million yuan, a decrease of 8.39% to 57.66% compared to the same period last year. It is expected that the net profit after deducting non-recurring gains and losses will be a loss of 58.37 million to 83.37 million yuan, a decrease of 141.79% to 245.36% compared to the same period last year. The expected operating revenue is between 150 million and 190 million yuan, with the operating revenue after deductions expected to be between 140 million and 180 million yuan. The company's stock trading may be subject to delisting risk warnings after the disclosure of the 2024 annual report

### Related Stocks

- [002693.CN](https://longbridge.com/en/quote/002693.CN.md)

## Related News & Research

- [ONE44 Analytics, How To Find The Long Term Fibonacci Retracements, New Video](https://longbridge.com/en/news/297530417.md)
- [15:10 ETHas Anyone Tried Gundry MD Vital Reds? Read Reviews, Ingredients, Benefits & More](https://longbridge.com/en/news/297553063.md)
- [Do Luxempart's (BDL:LXMPR) Earnings Warrant Your Attention?](https://longbridge.com/en/news/297594915.md)
- [Trump announces Medicaid drug pricing deals with 9 firms](https://longbridge.com/en/news/297557074.md)
- [Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President](https://longbridge.com/en/news/297630906.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**